China Biologic Products Holdings, Inc.
CBPO
CBPO was delisted on the 20th of April, 2021.
65 hedge funds and large institutions have $953M invested in China Biologic Products Holdings, Inc. in 2014 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 5 closing their positions.
240% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 5
80% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 15
32% more capital invested
Capital invested by funds: $724M → $953M (+$229M)
20% more funds holding
Funds holding: 54 → 65 (+11)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
80% less call options, than puts
Call options by funds: $807K | Put options by funds: $4.05M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$9.53M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.31M |
| 3 |
PA
Perceptive Advisors
New York
|
+$4.44M |
| 4 |
Morgan Stanley
New York
|
+$3.66M |
| 5 |
Renaissance Technologies
New York
|
+$3.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$1.11M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$602K |
| 3 |
D.E. Shaw & Co
New York
|
-$538K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$509K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$497K |
CBPO Hedge Fund Activity: Q4 2014 in Review
65 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q4 2014, worth a combined $953M — up 32% from $724M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CBPO positions and 5 closed out — a net gain of 12 holders — while 27 added to existing stakes and 15 trimmed.
The largest buyer was Matthews International Capital Management, opening a new position worth an estimated $9.53M. The largest seller was Invesco, cutting an estimated $1.11M.
- 65 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q4 2014, up from 54 in Q3 2014.
- Funds reported $953M of China Biologic Products Holdings, Inc. stock for Q4 2014, up 32% quarter-over-quarter.
- 17 funds opened new China Biologic Products Holdings, Inc. positions in Q4 2014 and 5 closed out, a net change of +12 holders.
- The largest China Biologic Products Holdings, Inc. buyer in Q4 2014 was Matthews International Capital Management, an estimated $9.53M added.
- The largest China Biologic Products Holdings, Inc. seller in Q4 2014 was Invesco, an estimated $1.11M sold.
Based on aggregated 13F filings for Q4 2014.